1 Min Read
Nov 27 (Reuters) - Novartis Ag:
* SAYS ULTIBRO® BREEZHALER® SIGNIFICANTLY IMPROVED COPD PATIENTS’ LUNG FUNCTION AFTER DIRECT SWITCH FROM SERETIDE Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.